Our Concept
To bring together a consortium of leading European researchers spanning the field from genetics, through pancreatic beta-cells, dendritic cell and T-cell biology towards clinical interventions, allowing the development of novel and logical interventional therapies in Type 1 Diabetes.
We propose to pioneer the concept of tailored interventions with minimal immune system interference in new onset Type 1 Diabetes, leading to beta-cell protection and restoration, based on a solid understanding of the disease pathogenesis, enabling our experimental findings to be adopted for future clinical application.
